D-0074-2023 Class III Terminated

Recalled by Acella Pharmaceuticals, LLC — Alpharetta, GA

FDA drug recall D-0074-2023 was initiated by Acella Pharmaceuticals, LLC on Nov 14, 2022 and is designated Class III. Reason for recall: Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period. The recall status is terminated (terminated Aug 1, 2024). Affected quantity: 528 cartons.

Recall details

Product Type
Drugs
Report Date
Dec 7, 2022
Initiation Date
Nov 14, 2022
Termination Date
Aug 1, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
528 cartons

Product description

Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60

Reason for recall

Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.

Distribution pattern

USA Nationwide

Code information

Lot#: 21084, 21085, Exp 06/30/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0074-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0074-2023. Report a data issue: hello@regdatalab.com.